Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530945 · ClinicalTrials.gov registry record
Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 227
- Enrollment target
NCT01530945 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 227 participants.
The verdict
NCT01530945 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
Patients with end-stage kidney disease (ESKD) must manage not only the demands of dialysis and comorbid conditions but also associated symptoms and acute life-threatening events that contribute to functional limitations and increased risk of mortality. Yet little is known about the trajectories of quality of life dimensions in patients with ESKD when they experience acute life-threatening episodes, to guide palliative care for this population. In this prospective, descriptive study, we will identify trajectories of symptoms, physical functioning, psychosocial needs, and emotional and spiritual well-being in 200 patients with ESKD who are at a high risk of experiencing acute life-threatening events and mortality within 12 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01530945
The ClinicalTrials.gov registry entry for NCT01530945 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01530945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01530945 about?
NCT01530945 is a clinical study titled "Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease". Patients with end-stage kidney disease (ESKD) must manage not only the demands of dialysis and comorbid conditions but also associated symptoms and acute life-threatening events that contribute to functional limitations and increased risk of mortality. Yet little is known about the trajectories of q...
What is the current status of trial NCT01530945?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2012-03. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT01530945?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.